US HB6802 | 2023-2024 | 118th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 6-1)
Status: Introduced on December 14 2023 - 25% progression, died in committee
Action: 2023-12-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 14 2023 - 25% progression, died in committee
Action: 2023-12-15 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
Title
RAPID Reserve Act Rolling Active Pharmaceutical Ingredient and Drug Reserve Act
Sponsors
Rep. Angela Craig [D-MN] | Rep. Jeff Van Drew [R-NJ] | Rep. Abigail Spanberger [D-VA] | Rep. Eleanor Norton [D-DC] |
Rep. Chrissy Houlahan [D-PA] | Sen. Elissa Slotkin [D-MI] | Rep. Darren Soto [D-FL] |
History
Date | Chamber | Action |
---|---|---|
2023-12-15 | House | Referred to the Subcommittee on Health. |
2023-12-14 | House | Referred to the House Committee on Energy and Commerce. |
2023-12-14 | House | Introduced in House |
Same As/Similar To
SB2510 (Same As) 2023-07-26 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/6802/all-info |
Text | https://www.congress.gov/118/bills/hr6802/BILLS-118hr6802ih.pdf |